Diosgenin attenuates nonalcoholic fatty liver disease through mTOR-mediated inhibition of lipid accumulation and inflammation
Guoliang Yin, Hongyi Liang, Yiran Cheng, Suwen Chen, Xin Zhang, Decheng Meng, Wenfei Yu, Hongshuai Liu, Chaoyuan Song, Fengxia Zhang, Fengxia Zhang
Topics & Concepts
Nonalcoholic fatty liver diseaseDiosgeninInflammationPI3K/AKT/mTOR pathwayLipid accumulationMedicineFatty liverDiseaseChemistryInternal medicineBiochemistryApoptosisOrganic chemistryLiver Disease Diagnosis and TreatmentDiet, Metabolism, and DiseaseAlcohol Consumption and Health Effects